Antitumor Activity of Dehydroxymethylepoxyquinomicin (DHMEQ) in Monotherapy and Combination with Cisplatin in the SKOV-3 Ovarian Cancer Model. J. Can. Res. Updates [Internet]. 2024 Sep. 2 [cited 2026 May 2];13:12-8. Available from: https://www.neoplasiaresearch.com/index.php/jcru/article/view/777